Advisory Committee

Timothy C. Allen, MD, JD, FCAP, is professor and chair of the pathology department at the University of Mississippi Medical Center in Jackson, Mississippi. Dr. Allen is certified by the American Board of Pathology in anatomic and clinical pathology, with added qualification in cytopathology. He is an associate editor of the Archives of Pathology and Laboratory Medicine, and author and coauthor of numerous articles and book chapters on pulmonary pathology and medico-legal issues. He is also coeditor of the Advances in Surgical Pathology series.

Dr. Allen serves as a governor on the College of American Pathologists Board of Governors. He is the immediate past-president of the Pulmonary Pathology Society and a past-president of the Texas Society of Pathologists.

Sandra M. Brown, MS, LCGC, is manager of the cancer genetics program at St. Joseph Hospital in Orange, California. Prior to joining St. Joseph Hospital, Ms. Brown served as the cancer genetic counselor for MemorialCare Health System. She is an active member of several international, national, state, and regional patient advocate, policy, and research networks for inherited cancers including ACCC, California Department of Health Care Services - Every Woman Counts, Lynch Syndrome Screening Network, Facing Our Risk of Cancer Empowered, Ovarian Cancer Orange County Alliance, and the International Clinical Cancer Genetics Community Research Network.

She frequently addresses professional, national association, and lay audiences; collaborates on important research; and provides leadership to cancer risk awareness campaigns and support groups. Ms. Brown obtained her master’s in human/medical genetics from the University of California, Irvine.

Pablo Gutman, MD, MBA, is Chairman of the Pathology Department and Medical Director of the Cancer Institute at Holy Cross Health (a 500+ bed hospital system in the Washington D.C. metropolitan area). He is Board Certified in Anatomical Pathology, Clinical Pathology, Hematopathology and Cytopathology. As a pathologist, he has become particularly interested in optimizing tissue acquisition and processing for diagnosis and molecular testing of tumors, as well as simplifying and integrating molecular data into pathology reports and the electronic medical record. As Medical Director of the Cancer Institute at Holy Cross Health, he is heavily involved in strategic and operational aspects of running one of the busiest Cancer Centers in the State of Maryland. In his somewhat limited free time, Dr, Gutman enjoys sailing, woodworking, hiking, and spending time with his family both in the U.S. and abroad.

Dana Herndon, RN, BSN, is a thoracic oncology nurse navigator at Cone Health Cancer Center at Wesley Long Hospital in Greensboro, North Carolina. Ms. Herndon holds a bachelor’s in nursing from the University of North Carolina at Greensboro. 

Jeremiah Martin, MBBCh, MSCRD, FRCSI, is a thoracic and cardiac surgeon at Southern Ohio Medical Center. He completed his minimally invasive thoracic surgery and lung transplantation fellowship at Duke University Hospital in 2012.

Dr. Martin practiced at the University of Kentucky for four years before moving to Southern Ohio where he has resided for over two years.

Mohamed K. Mohamed, MD, PhD, is a practicing hematologist and oncologist, and director of the Thoracic Oncology Program at Cone Health Cancer Center in Greensboro, North Carolina. Dr. Mohamed specializes in internal medicine and oncology. He completed his hematology/oncology fellowship at the University of Pittsburgh.

Jan Nowak, MD, PhD, is clinical chief of molecular pathology and professor of oncology at Roswell Park Comprehensive Cancer Center. Dr. Nowak is certified in molecular genetic pathology and anatomic and clinical pathology. His areas of expertise include anatomic, clinical, and molecular pathology; laboratory management; laboratory regulatory oversight; and laboratory and professional services coding and reimbursement.

Dr. Nowak obtained his medical degree from the University of Rochester School of Medicine and doctorate in biophysics from the University of Rochester in Rochester, New York.

Vivian Pan, MS, LCGC, is the director of genetic counseling services and manager of the cancer genetics program at Cook County Health and Hospitals System in Illinois. Prior to joining Cook County Health and Hospitals System, Ms. Pan led the Translational Research Core at Kaiser Permanente Research Bank. She is an active member of the Illinois Society for Genetic Professionals, Midwest Genetics Network, National Society of Genetic Counselors, and the Accreditation Council for Genetic Counseling. Ms. Pan is also a faculty member, a clinical supervisor, and co-coordinator of the Research Methods course for the Graduate Program in Genetic Counseling at Northwestern University. Her professional and research interests include implementation of genomic medicine in clinical care, access/delivery of genetic counseling services, and health equity.

She received her master’s degree in genetic counseling from Northwestern University.

Michelle Shiller, DO, AP/CP, MGP, became board certified in Anatomic, Clinical, and Molecular Genetic Pathology following the completion of her residency at Baylor University Medical Center in Dallas, Texas, and her fellowship at The Mayo Clinic in Rochester, Minnesota. Upon completion of her training, Dr. Shiller established a practice with Pathologists Biomedical Laboratories in Dallas, Texas, which services the majority of the Dallas/Ft. Worth Metroplex Baylor Scott and White Hospitals. Dr. Shiller sits on the Quality Committee for the Baylor Sammons Cancer Center; serves as the Assistant Medical Director for Cancer Genetics, primarily focusing on germline cancer predisposition; and is the Co-Assistant Medical Director for the Division of Molecular Medicine and Pathology. Dr. Shiller has also served on the Baylor Medical Board. Dr. Shiller has served on steering committees and advisory boards for multiple entities. She is an active member of the Association for Molecular Pathology, where she has developed a consistent dialogue between molecular pathology and oncology, and she assists with developing the ASCO-sponsored Molecular Tumor Board..